Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Update on the antidiabetic effects of sitagliptin

July 8, 2005

Pancreatic B-cell-selective potassium channel opener reported

July 8, 2005

LAB begins phase II study for GHRH analogue

July 8, 2005

Emisphere receives first milestone in Roche collaboration

July 8, 2005

Lilly licenses oral DPP-IV inhibitor from Taisho

July 8, 2005

Ranirestat improves nerve conduction velocity in DSP patients

July 8, 2005

CB1 receptor antagonist shows promise for osteoporosis treatment

July 7, 2005

Megace ES approved for anorexia, cachexia or weight loss in AIDS patients

July 7, 2005

Therapeutic benefits of rimonabant in prediabetes and obesity

July 7, 2005

Phase I study commences for intranasal parathyroid hormone

July 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...